The results showed that treatment of CFF‐1 dramatically decreased the protein levels of Ki‐67, p‐EGFR (Y1173), and p‐AKT (S473) in tumor tissues in vivo (Fig. 8E). The gene discussed is HCFC1; the disease is neoplasm.